Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 15,885,000	$ 6,033,000
Awards receivable	335,000
Prepaid expenses and other current assets	804,000	622,000
Total current assets	17,024,000	6,655,000
Restricted cash	1,200,000	700,000
Property and equipment, net	1,950,000	2,187,000
Operating lease right-of-use asset	10,869,000	2,028,000
In-process research and development	10,256,000	10,256,000
Goodwill	3,490,000	3,490,000
Other assets	886,000	135,000
Total assets	45,675,000	25,451,000
Current liabilities
Accounts payable and accrued liabilities	1,871,000	1,278,000
Accrued compensation	1,302,000	1,323,000
Deferred asset acquisition consideration	1,771,000	970,000
Current portion of operating lease liabilities	1,406,000	1,308,000
PPP Loan	720,000
Total current liabilities	7,070,000	4,879,000
Operating lease liabilities, net of current portion	10,909,000	1,555,000
Deferred asset acquisition consideration, net of current portion		1,347,000
Deferred tax liability	3,077,000	3,077,000
Total liabilities	21,056,000	10,858,000
Stockholders' equity
Common stock, $0.01 par value; 217,000,000 shares authorized; 18,668,883 and 9,922,758 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	187,000	99,000
Additional paid-in capital	197,510,000	172,015,000
Accumulated deficit	(173,078,000)	(157,521,000)
Total stockholders' equity	24,619,000	14,593,000
Total liabilities and stockholders' equity	$ 45,675,000	$ 25,451,000